BRCA1 and cancer: Although in cellulo assays would provide supportive evidence for biological impact predicted by bioinformatic tools, the causality of an intronic variant identified in an established highly penetrant cancer predisposing gene such as BRCA1 in conferring risk to cancer remains a challenge.